Brentuximab Vedotin Plus Bendamustine in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Meta-Analysis

被引：1
|
作者：
Abdelgawad, Hussien Ahmed H. [1 ,2 ]
Belal, Mohamed Mohamed [3 ]
Bashir, Mohamed Nabih [3 ]
Aboeldahab, Heba [4 ,5 ]
Eshun, Francis [1 ,2 ]
Otto, Mario [1 ,2 ]
Henry, Michael [1 ,2 ]
机构：
[1] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA
[2] Phoenix Childrens Hosp, Ctr Canc & Blood Disorders, Phoenix, AZ USA
[3] Alexandria Univ, Fac Med, Alexandria, Egypt
[4] El Gomhoria Gen Hosp, Clin Res Dept, Alexandria, Egypt
[5] Alexandria Univ, Med Res Inst, Biomed Informat & Med Stat Dept, Alexandria, Egypt
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187466
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous transplant: meta-analysis versus historical data
    Bonthapally, Vijayveer
    Wu, Eric
    Macalalad, Alexander
    Yang, Hongbo
    Shonukan, Oluwatoyin
    Liu, Yi
    Chi, Andy
    Huebner, Dirk
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (05) : 993 - 1001
  • [42] BRENTUXIMAB VEDOTIN PLUS HIGH-DOSE BENDAMUSTINE IS EFFECTIVE AND HAS A FAVOURABLE TOXICITY PROFILE IN THE TREATMENT OF REFRACTORY OR RELAPSED HODGKIN LYMPHOMA
    Cerchione, C.
    Picardi, M.
    Di Perna, M.
    Pugliese, N.
    Della Pepa, R.
    Pane, F.
    HAEMATOLOGICA, 2017, 102 : 107 - 107
  • [43] Brentuximab Vedotin Plus Bendamustine: As Salvage Regimen for Relapsed or Refractory Hodgkin Lymphoma, King Abdulaziz Medical City - Jeddah - KSA Experience
    Althomali, Muteb
    Absi, Ahmad
    El Hemaidi, Ihab
    Warsi, Ashraf
    AlAmoudi, Sameer
    Alahmadi, Majed
    Rajkhan, Walaa
    Almutairi, Sultan
    Eldadah, Saleem
    Khalil, Manar
    Adam, Muna
    Ali, Syed Adnaan
    Alghamdi, Abdulrahman
    Alsaeed, Ahmad
    BLOOD, 2019, 134
  • [44] A Phase II Study of Brentuximab Vedotin and Bendamustine for Relapsed/Refractory Follicular Lymphoma
    Kaleka, Guneet
    Moskoff, Benjamin
    Zafar, Aneeqa
    Esteghamat, Naseem S.
    Abedi, Mehrdad
    Socola, Francisco Andres
    Hoeg, Rasmus T.
    Tuscano, Joseph M.
    BLOOD, 2024, 144 : 6318 - 6319
  • [45] Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital
    Alrajhi, Abdullah M.
    Aljalali, Razan A.
    Alghazi, Lara H.
    Asiri, Ibrahim
    Alnakhli, Adel
    Alnajjar, Fouad H.
    Alshehry, Nawal F.
    Motabi, Ibraheem H.
    Alnoamani, Mohammed S.
    Marei, Mohammed A.
    Alfayez, Mansour
    Tailor, Imran K.
    BLOOD, 2021, 138
  • [46] BRENTUXIMAB VEDOTIN FOLLOWED BY BENDAMUSTINE SUPERCHARGE FOR REFRACTORY OR RELAPSED HODGKIN LYMPHOMA: MATURE RESULTS OF A MONOCENTRIC PROSPECTIVE TRIAL
    Della Pepa, R.
    Picardi, M.
    Pugliese, N.
    Giordano, C.
    Leone, A.
    Muriano, F.
    Pane, F.
    HAEMATOLOGICA, 2020, 105 : S101 - S102
  • [47] A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin
    Cao, Zhi-Gang
    Zhou, Hong-Wei
    Peng, Chao-Jin
    Liu, Mo
    Du, Yu
    Yang, Qing-Ming
    CHINESE JOURNAL OF CANCER, 2013, 32 (09) : 520 - 523
  • [48] Combination of nivolumab with brentuximab vedotin in therapy of relapsed and refractory Hodgkin lymphoma
    Fedorova, L.
    Lepik, K.
    Mikhailova, N.
    Kondakova, E.
    Kotselyabina, P.
    Shmidt, D. I.
    Kozlov, A.
    Zalyalov, Y.
    Borzenkova, E.
    Baykov, V.
    Moiseev, I.
    Kulagin, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S655 - S655
  • [49] EXPERIENCE WITH BRENTUXIMAB VEDOTIN IN RELAPSED/ REFRACTORY HODGKIN LYMPHOMA IN THE PROVINCE OF CADIZ
    Verdugo Cabeza De Vaca, Ma V.
    Cuellar Garcia, C.
    Romero Gonzalez, Ma dM
    Fernandez Valle, Ma dC
    Berruezo Salazar, Ma J.
    Paz Coll, A.
    Garzon Lopez, S.
    HAEMATOLOGICA, 2015, 100 : 174 - 174
  • [50] Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
    Angelopoulou, Maria K.
    Vassilakopoulos, Theodoros P.
    Batsis, Ioannis
    Sakellari, Ioanna
    Gkirkas, Konstantinos
    Pappa, Vasiliki
    Giannoulia, Panagiota
    Apostolidis, Ioannis
    Apostolopoulos, Christos
    Roussou, Paraskevi
    Panayiotidis, Panayiotis
    Dimou, Maria
    Kyrtsonis, Marie-Christine
    Palassopoulou, Maria
    Vassilopoulos, Georgios
    Moschogiannis, Maria
    Kalpadakis, Christina
    Margaritis, Dimitrios
    Spyridonidis, Alexander
    Michalis, Eurydiki
    Anargyrou, Konstantinos
    Repousis, Panagiotis
    Hatzimichael, Eleutheria
    Bousiou, Zoi
    Poulakidas, Elias
    Grentzelias, Dimitrios
    Harhalakis, Nikolaos
    Pangalis, Gerassimos A.
    Anagnostopoulos, Achilles
    Tsirigotis, Panagiotis
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 174 - 181
12345